#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile chronic myelomonocytic leukaemia Mantle cell lymphoma refractory Erythema Hepatoblastoma Enteritis Frontotemporal dementia Chronic lymphocytic leukaemia recurrent Cytomegalovirus infection Hereditary hypophosphataemic rickets Angiosarcoma non-metastatic Subdural haematoma Juvenile idiopathic arthritis PIK3CA-activated mutation Philadelphia positive chronic myeloid leukaemia Pulmonary tuberculosis More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Brain stem glioma Marginal zone lymphoma – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Amyotrophic lateral sclerosis – Diagnostics Epidermolysis bullosa – Basic Information Systemic sclerosis pulmonary – Basic Information Pleural mesothelioma malignant – Diagnostics Hyperoxaluria – Life with Disease Hereditary ataxia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AB521 Volrustomig Azilsartan Medoxomil Izaflortaucipir (18F) Ketamine Etelcalcetide Volixibat POTASSIUM HYDROXIDE Paclitaxel Albumin-Bound Entrectinib Temozolomide Aup1602-C Tirzepatide Ioversol Sodium Iotalamate (125I) Clebopride Hydrogen Maleate Sotrovimab Ht-29-B Remifentanil Hydrochloride Lurbinectedin More therapies…

    Learn about Your Condition

    Krabbe's disease Extra-osseous Ewing's sarcoma Vulval cancer recurrent Petit mal epilepsy Bronchitis Myeloproliferative neoplasm Mitral valve prolapse Knee arthroplasty Plasma cell myeloma Heart disease congenital Breast cancer stage II Neurofibromatosis Skin cancer HER2 positive breast cancer Pseudomonas infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Réunion

CHU Réunion

Allée des Topazes CS11021, St Denis, 97400, Réunion

Want to learn more about this study or check if you can participate? Contact us.

  • Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone Sodium Succinate
    • Vindesine Sulfate
    • Mitoxantrone
    Austria Czechia Denmark Finland France Germany +5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!